GSK
(ETR) GS7
GSK Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$35.31B
Net Income (TTM)
$5.21B
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
GS7 News
GS7: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout GSK
Industry
Pharmaceuticals
Sector
Health CareEmployees
66,841
CEO
Emma N. Walmsley
Website
www.gsk.comHeadquarters
Brentford, TW8 9GS, GB
GS7 Financials
Key Financial Metrics (TTM)
Gross Margin
72%
Operating Margin
22%
Net Income Margin
17%
Return on Equity
37%
Return on Capital
18%
Return on Assets
9%
Earnings Yield
N/A
Dividend Yield
3.01%
Payout Ratio
44.86%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$22.51B
Operating Income
$5.51B
EBITDA
$8.75B
Operating Cash Flow
$7.95B
Capital Expenditure
$2.93B
Free Cash Flow
$5.02B
Cash & ST Invst.
$4.33B
Total Debt
$24.17B
GSK Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$6.93B
-14.4%
Gross Profit
$4.75B
-14.2%
Gross Margin
68.60%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
90,096
N/A
Net Income
$746.00M
-51.5%
EBITDA
$1.73B
-25.6%
Quarterly Fundamentals
Net Cash
$15.58B
+28.9%
Accounts Receivable
$0.00
N/A
Inventory
$4.66B
-26.3%
Long Term Debt
$18.78B
-8.1%
Short Term Debt
$3.33B
-34.0%
Return on Assets
9.35%
N/A
Return on Invested Capital
18.05%
N/A
Free Cash Flow
$1.21B
+91.6%
Operating Cash Flow
$1.64B
+26.5%